ATR and familial pancreatic carcinoma: In PSN-1, MiaPaCa-2 and primary PancM pancreatic cancer cells, VE-821, as the first highly selective and potent ATR inhibitor, increased sensitivity to radiation doses of 2, 4 and 6 Gy in vitro[93].